Newsletter Archive

11. 02.04.20 -- Are You Prepared For Impending Changes To U.S. Biologics & Biosimilars Law? 2/4/2020
    02/04/20 Pharmaceutical Online Newsletter
12. 02.03.20 -- Faster Assessment Of Monoclonal Antibody Functionality 2/3/2020
    02/03/20 Pharmaceutical Online Newsletter
13. 01.31.20 -- Considerations For Bringing Biologics To Market 1/31/2020
    01/31/20 Pharmaceutical Online Newsletter
14. 01.30.20 -- An Introduction To Forced Degradation Studies For Drug Substance And Drug Product 1/30/2020
    01/30/20 Pharmaceutical Online Newsletter
15. 01.29.20 -- Forging The Path For Efficient And Economical Viral Vector Production 1/29/2020
    01/29/20 Pharmaceutical Online Newsletter
16. 01.28.20 -- EMA Publishes Updates To Its New Requirements For Nitrosamines 1/28/2020
    01/28/20 Pharmaceutical Online Newsletter
17. 01.27.20 -- Strategies For Oral Formulation Development 1/27/2020
    01/27/20 Pharmaceutical Online Newsletter
18. 01.24.20 -- How To Achieve Unique Synergies In Antibody Expression 1/24/2020
    01/24/20 Pharmaceutical Online Newsletter
19. 01.23.20 -- Packaging Good Manufacturing Practices (GMPs) For Medicinal Products 1/23/2020
    01/23/20 Pharmaceutical Online Newsletter
20. 01.22.20 -- Considerations For Shipping Biologics 1/22/2020
    01/22/20 Pharmaceutical Online Newsletter